相关产品推荐更多 >

Obinutuzumab (anti-CD20),949142-50-1,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥589.90
Belantamab (anti-TNFRSF17),2061894-48-0,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥609.90
TLR7/8 agonist 4,2388520-33-8,10mM in DMSO,阿拉丁
¥5500.90
Bemarituzumab (anti-FGFR2),1952272-74-0,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC),阿拉丁
¥479.90
JC2-11,937820-89-8,≥98%,阿拉丁
¥1100.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-80℃储存;避免反复冻融
- 英文名:
Faricimab (anti-ANG2&VEGFA)
- 库存:
期货
- 供应商:
上海阿拉丁生化科技股份有限公司
- CAS号:
1607793-29-2
- 规格:
Ab175535-1mg/Ab175535-100μg
| 规格: | Ab175535-1mg | 产品价格: | ¥7399.9 |
|---|---|---|---|
| 规格: | Ab175535-100μg | 产品价格: | ¥1479.9 |
Faricimab (anti-ANG2 & VEGFA) 是一种双特异性抗体,靶向 angiopoietin-2 和血管内皮生长因子-A (VEGF-A)。Faricimab (anti-ANG2 & VEGFA) 可用于糖尿病黄斑水肿 (DME) 研究。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
, passage the cells more sparsely ( Fig. 1a ). Freezing ESCs 25. Passage the ESCs as described in Step 22. Resuspend the cells in 3 mL of freezing medium for OP9 cells. 26. Aliquot 1 mL of cell suspension per cryovial (~3-6 x
Studies of the Ubiquitin Proteasome System
phosphatase inhibitors and 50 µM MG132 (or lactacystin) Anti‐E3 or anti‐substrate antibody Nondenaturing Triton X‐100 wash buffer (see recipe ) Tris‐buffered saline (TBS
Reprogramming Fibroblasts with the CytoTune-iPS Reprogramming Kit
9. GlutaMAX™-I Supplement 10. Basic FGF, Recombinant Human 11. β-Mercaptoethanol, 1000X 12. Penicillin-Streptomycin, Liquid 13. Attachment Factor 14. TrypLE™ Select Cell Dissociation Reagent or 0.05% Trypsin/EDTA
技术资料暂无技术资料 索取技术资料






